{"id":"W2946986050","doi":"10.1016/j.clgc.2019.05.012","title":"Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Pfizer Canada; Bristol-Myers Squibb Canada; Orionin Tutkimussäätiö; Cilag; Astellas Pharma; Ipsen; Astellas Pharma Canada; Bristol-Myers Squibb; Bayer Corporation; Janssen Canada; Meso Scale Diagnostics; Sanofi; Roche; Novartis; Amgen; Pfizer; Johnson and Johnson; Takeda Pharmaceutical Company; Active Biotech; Bayer","keywords":"Medicine; Prostate cancer; Radium-223; Oncology; Disease; Internal medicine; Radium; Castration; Urology; Cancer; Hormone; Bone metastasis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005319121,0.0001531433,0.0002713442,0.0002975009,0.0002674843,0.0003606428,0.000197691,0.0002919392,0.001453765],"category_scores_gemma":[0.001323343,0.0001259605,0.0003078687,0.0004812974,0.0001420301,0.000258238,0.0001760152,0.0004925348,0.0001571801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002791412,"about_ca_system_score_gemma":0.0003233514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001238365,"about_ca_topic_score_gemma":0.001772268,"domain_scores_codex":[0.9997941,0.00007200792,0.0000166667,0.00003997919,0.00004413568,0.00003316807],"domain_scores_gemma":[0.9985793,0.0002649242,0.0006700592,0.00003602699,0.00004947036,0.0004001656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002630491,0.0003096397,0.9933228,0.000016832,0.00007337193,0.00006992777,0.00004068828,0.0001587012,0.0005421157,0.00001214954,0.0001629901,0.002660299],"study_design_scores_gemma":[0.0001198336,0.0009848349,0.9981132,0.000004121512,0.00003579144,0.0001941625,0.00003736422,0.0002063282,0.00007209598,0.00001109157,0.00021758,0.000003619084],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993775,0.0001714152,0.00004050113,0.00003599069,0.000003017245,0.00001114741,0.000149169,0.000002336944,0.0002090023],"genre_scores_gemma":[0.9995912,0.00004514653,0.00003921565,0.00002324585,0.000008155168,0.00001050383,0.0001834144,0.000001218266,0.00009808462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001453765,"threshold_uncertainty_score":0.004863322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06678858482934684,"score_gpt":0.420381723733961,"score_spread":0.3535931389046141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}